Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
305 articles
Breakthrough therapy targeting B cells demonstrates significant improvement in lupus symptoms with sustained benefits over one year.
Chinese researchers test safer alternative to CAR-T therapy for lupus patients, achieving remission in 67% with minimal side effects.
New analysis reveals comparable effectiveness between JAK inhibitors and biological therapies for rheumatoid arthritis patients.
Study reveals how specific antibodies affect tolerance to different rheumatoid arthritis medications, offering personalized treatment insights.
FIRST-RA study follows 300 patients to measure early pain relief and functional improvements with filgotinib treatment.
Advanced lung biopsy technique uncovers serious pneumonia complications from methotrexate treatment in rheumatoid arthritis patients.
Advanced genetic analysis reveals new pathways to personalized RA therapy, addressing treatment failures in 30-40% of patients.
Study of 61 RA patients reveals 85% satisfaction with knee replacement, with quality of life improvements predicting success better than clinical measures.
New research reveals JAK inhibitors significantly increase hearing loss when combined with aminoglycoside antibiotics.
New study reveals how 2023 drug safety warnings led to less effective treatment choices for rheumatoid arthritis patients.
Systematic review of 87 clinical trials reveals JAK inhibitors offer targeted therapy for rheumatoid arthritis with distinct safety profiles.
Researchers identify protein stress as key factor limiting natural killer cell survival in cancer treatment.
